0001209191-23-044838.txt : 20230807
0001209191-23-044838.hdr.sgml : 20230807
20230807165133
ACCESSION NUMBER: 0001209191-23-044838
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230804
FILED AS OF DATE: 20230807
DATE AS OF CHANGE: 20230807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Heery Christopher
CENTRAL INDEX KEY: 0001789632
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41259
FILM NUMBER: 231148246
MAIL ADDRESS:
STREET 1: C/O PRECISION BIOSCIENCES, INC.
STREET 2: 302 E. PETTIGREW STREET, SUITE A-100
CITY: DURHAM
STATE: NC
ZIP: 27701
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcellx, Inc.
CENTRAL INDEX KEY: 0001786205
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 472855917
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25 WEST WATKINS MILL ROAD
STREET 2: SUITE A
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
BUSINESS PHONE: 240-723-6641
MAIL ADDRESS:
STREET 1: 25 WEST WATKINS MILL ROAD
STREET 2: SUITE A
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-04
0
0001786205
Arcellx, Inc.
ACLX
0001789632
Heery Christopher
C/O ARCELLX, INC.
25 WEST WATKINS MILL ROAD, SUITE A
GAITHERSBURG
MD
20878
0
1
0
0
Chief Medical Officer
0
Common Stock
2023-08-04
4
M
0
3000
15.00
A
10795
D
Common Stock
2023-08-04
4
S
0
3000
35.3778
D
7795
D
Common Stock
15.00
2023-08-04
4
M
0
3000
0.00
D
2032-02-03
Common Stock
3000
215205
D
The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on June 30, 2022.
Represents the weighted average share price of an aggregate total of 3,000 shares sold in the price range of $35.00 to $35.98 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2022 Equity Incentive Plan) through each applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option will vest each month following Equity Grant Date on the same day of the month as the Equity Grant Date (or, if there is no corresponding day in a particular month, then the last day of the month) over four (4) years. "Equity Grant Date" shall mean February 3, 2022.
/s/ Michelle Gilson, as Attorney-in-Fact
2023-08-07